PDB 6a3n
PDB Information
PDB | 6A3N |
Method | X-RAY DIFFRACTION |
Host Organism | Escherichia coli BL21 |
Gene Source | Homo sapiens |
Primary Citation | Discovery of Potent, Selective, and Orally Bioavailable Inhibitors against Phosphodiesterase-9, a Novel Target for the Treatment of Vascular Dementia.
J. Med. Chem.
|
Header | Hydrolase |
Released | 2018-06-15 |
Resolution | 2.600 |
CATH Insert Date | 14 Apr, 2019 |
PDB Images (5)
PDB Prints
PDB Chains (2)
Chain ID | Date inserted into CATH | CATH Status |
---|---|---|
A | 14 Apr, 2019 | Chopped |
B | 14 Apr, 2019 | Chopped |
CATH Domains (2)
Domain ID | Date inserted into CATH | Superfamily | CATH Status |
---|---|---|---|
6a3nA00 | 15 Apr, 2019 | 1.10.1300.10 | Assigned |
6a3nB00 | 15 Apr, 2019 | 1.10.1300.10 | Assigned |
UniProtKB Entries (2)
Accession | Gene ID | Taxon | Description |
---|---|---|---|
O76083 | PDE9A_HUMAN | Homo sapiens | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A |
O76083 | PDE9A_HUMAN | Homo sapiens | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A |